Tag:
Iplex
Latest Headlines
Latest Headlines
Insmed shares tank on mid-stage trial failure
Insmed's lead drug failed to show efficacy in a mid-stage clinical trial of a genetic condition called myotonic muscular dystrophy and investors swiftly hammered the stock, sending down shares more
